Robert E. Hollingsworth

Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies

R. Hollingsworth, R. Herbst, Jiaqi Huang, 2017, Oncogene.